Skip to content
Baltimore News Journal – Lifestyle
Author:
Cipla
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US
September 3, 2026